Autori: Livingstone E
| Naslov | Early switch from run-in with targeted to immunotherapy in advanced BRAFV600-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial (Article) |
| Autori | Livingstone E ... Kandolf Lidija O ... (broj koautora 25) |
| Info | ESMO OPEN, (2025), vol. 10 br. 5, str. - |
| Projekat | F. Hoffmann-La Roche Ltd. [MO29821-UKE]; F. Hoffmann-La Roche; University Hospital Essen |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
| Naslov | Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial (Article) |
| Autori | Livingstone E ... Kandolf-Sekulovic Lidija O ... Mijuskovic Zeljko P ... (broj koautora 24) |
| Info | EUROPEAN JOURNAL OF CANCER, (2023), vol. 190 br. , str. - |
| Projekat | F. Hoffmann-La Roche Ltd |
| Ispravka | ISI/Web of Science Članak Elečas Rang časopisa |
